Target Price | $7.00 |
Price | $4.99 |
Potential |
40.26%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Onconova Therapeutics Inc. price target 2025.
The average Onconova Therapeutics Inc. target price is $7.00.
This is
40.26%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Onconova Therapeutics Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Onconova Therapeutics Inc. stock has an average upside potential 2025 of
40.26%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.23 | 0.23 |
0.00% | 0.00% | |
Net Margin | -9,911.17% | -64,113.04% |
2,380.22% | 546.88% |
1 Analyst has issued a sales forecast Onconova Therapeutics Inc. 2024 . The average Onconova Therapeutics Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Onconova Therapeutics Inc. 2024 . The average Onconova Therapeutics Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -22.57 | -146.00 |
2,380.22% | 546.88% | |
P/E | negative | |
EV/Sales | 477.52 |
1 Analysts have issued a Onconova Therapeutics Inc. forecast for earnings per share. The average Onconova Therapeutics Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Onconova Therapeutics Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Onconova Therapeutics Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.